tiprankstipranks
Catalyst Pharma (DE:CN2)
FRANKFURT:CN2

Catalyst Pharma (CN2) Stock News & Sentiment

3 Followers
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
PremiumPress Releases
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
22d ago
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
PremiumPress Releases
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
23d ago
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
PremiumPress Releases
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
1M ago
‘Time to Hit Buy,’ Says Bank of America About These 3 Stocks
PremiumStock Analysis & Ideas
‘Time to Hit Buy,’ Says Bank of America About These 3 Stocks
1M ago
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
PremiumPress Releases
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
1M ago
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2M ago
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
PremiumPress Releases
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
2M ago
More CPRX News >

News Score - Last 7 Days

Neutral
DE:CN2
Sector Average
Media Buzz
This Week2 articles
Weekly Average2.25 articles
News Sentiment
This Week50%
Sector Average62%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:CN2’s Media Buzz Sentiment?
2 articles about DE:CN2 were published this week. In an average week, 2.25 articles are published.
    What is DE:CN2’s weekly average amount of articles?
    In an average week, 2.25 articles about DE:CN2 are published.
      What is DE:CN2’s News Sentiment?
      50% of articles about DE:CN2 were positive this week, compared to its sector average of 62%.
        Healthcare Stocks that are Trending in the News
        ELVElevance Health
        CGEMCullinan Management
        MRNSMarinus
        EWEdwards Lifesciences
        INSPInspire Medical Systems
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis